What are the safest oral muscle relaxants for an 80‑year‑old patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Avoid All Traditional Muscle Relaxants in 80-Year-Old Patients

Traditional skeletal muscle relaxants (cyclobenzaprine, methocarbamol, carisoprodol, chlorzoxazone, metaxalone) should not be used in 80-year-old patients, and contrary to previous assumptions, baclofen and tizanidine are also unsafe and should be avoided. 1, 2

The Evidence Against All Muscle Relaxants

Traditional Muscle Relaxants Are Clearly Inappropriate

The 2020 JAGS guidelines explicitly state that traditional muscle relaxants "do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain" and are "not favored for chronic pain" in older adults due to their strong anticholinergic effects 1. The 2021 Mayo Clinic guidelines reinforce this, identifying cyclobenzaprine specifically as a strongly anticholinergic medication that causes vision problems, urinary retention, constipation, cognitive decline, falls, delirium, and emergency department visits 2.

A 2013 study demonstrated that older adults using traditional SMRs have a 32% increased risk of injury overall, with carisoprodol carrying a 73% increased risk, methocarbamol 42%, and cyclobenzaprine 22% 3.

Baclofen and Tizanidine Are Also Unsafe

The most recent 2025 evidence definitively shows that baclofen and tizanidine—previously thought to be safer alternatives—actually carry equal or greater injury risks than traditional muscle relaxants:

  • Baclofen demonstrates a 69% greater risk of injury compared to cyclobenzaprine 4
  • Tizanidine carries a 34% greater risk of injury compared to cyclobenzaprine 4
  • Baclofen has a 68% higher risk of falls compared to tizanidine and a 3.33-fold increased risk of delirium 5, 6

This 2025 research explicitly recommends that baclofen and tizanidine should be added to the Beers Criteria as potentially inappropriate medications for older adults 4.

What to Use Instead

For Musculoskeletal Pain:

  • Duloxetine (SNRI antidepressant) - evidence-based for chronic musculoskeletal pain 1
  • Tricyclic antidepressants (TCAs) at low doses - if anticholinergic burden is carefully monitored 1
  • NSAIDs or acetaminophen - for acute flares, with appropriate gastroprotection and renal monitoring

For Neuropathic Components:

  • Gabapentin (900-3600 mg/day in divided doses, though effective dose may be lower in 80-year-olds) 1
  • Pregabalin (150-600 mg/day in divided doses, adjust for age) 1

For Fibromyalgia or Chronic Widespread Pain:

  • Duloxetine as first-line 1
  • Pregabalin as alternative 1

Critical Pitfalls to Avoid

  1. Do not assume baclofen or tizanidine are "safer" alternatives - the newest evidence contradicts this assumption
  2. Watch for "anticholinergic burden" - multiple medications with anticholinergic properties compound cognitive and functional decline 2
  3. Muscle relaxants provide no benefit for chronic pain - they only have limited evidence for acute musculoskeletal pain (< 6 weeks), and even then the harm outweighs benefit in 80-year-olds 1, 7
  4. Sedation and falls are the primary concerns - these lead to fractures, hospitalizations, and mortality in this age group 4, 5, 3

The Bottom Line

In an 80-year-old patient, there is no "safe" oral muscle relaxant. All traditional agents and both baclofen and tizanidine carry unacceptable injury and fall risks. Redirect treatment toward duloxetine for musculoskeletal pain or gabapentinoids for neuropathic components, with careful dose titration and monitoring for adverse effects.

References

Guideline

a practical approach to using adjuvant analgesics in older adults.

Journal of the American Geriatrics Society (JAGS), 2020

Guideline

polypharmacy management in older patients.

Mayo Clinic Proceedings, 2021

Research

Safety of baclofen versus tizanidine for older adults with musculoskeletal pain.

Journal of the American Geriatrics Society, 2023

Research

Oral non-benzodiazepine muscle-relaxants for people with acute and chronic primary low back pain: a systematic review with meta-analysis.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.